Scientific Poster Publication made on March 2018 at the American Society for Clinical Pharmacology and Therapeutics, Orlando (USA).
Often, the primary endpoint of RCTs is defined as a change from baseline of a continuous outcome. In
such cases, regulators recommend including the outcome’s baseline value as a covariate in the
statistical analysis. Regression to the mean can explain the benefits of this procedure.
We modeled the regression to the mean effect in this context. We found that the correlation between
baseline and endpoint is a function of the outcome’s signal to noise ratio (SNR). The SNR is the ratio of
the inter-patient and the intra-patient variabilities. We observed that lower is the SNR, higher is the
correlation and more efficient is the covariate correction.
To increase this correction, we proposed to combine several baseline measurements in a covariate
minimizing the SNR with respect to the primary endpoint. This methodology was tested on placebo
patients of two studies in Neuropathic Pain. The continuous outcomes were the weekly mean of the
daily average pain score (APS), the brief pain inventory (BPI), and the worst pain score (WPS). The
primary endpoint was the change from baseline of the APS.
As covariate, the baseline value of the APS outcome was able to explain 10.8% of the primary endpoint
variance (Adj R-squared with p-value=0.00108). As proposed, we combined the baseline values of the
pain outcomes into a single covariate having a low SNR. This new covariate increased the explained
variance of the primary endpoint up to 28.5% (Adj R-squared with p-value<5e-08).
The correction for the baseline value of a continuous outcome is a standard procedure